Trafalgar International (GCAN) Total Debt Growth (1y) (2017 - 2023)
Trafalgar International (GCAN) Total Debt Growth (1y) (2017 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn | -3.69% |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 37.49% |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn | -2.48% |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 4.38% |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn | -6.91% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - | 41.53% |
| 10 | Trafalgar International | 236,233.75 | 236,233.75 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -90.89% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | -30.83% |
| Jun 30, 2022 | 0.88% |
| Mar 31, 2022 | -7.96% |
| Dec 31, 2021 | -55.57% |
| Sep 30, 2021 | 0.00% |
| Jun 30, 2021 | -13.63% |
| Mar 31, 2021 | -33.58% |
| Dec 31, 2020 | 125.08% |
| Sep 30, 2020 | 119.63% |
| Jun 30, 2020 | 25.80% |
| Mar 31, 2020 | 63.60% |
| Dec 31, 2019 | 0.00% |
| Sep 30, 2019 | 0.00% |
| Jun 30, 2019 | 1,247.22% |
| Mar 31, 2019 | 2,023.32% |
| Dec 31, 2018 | 2,525.73% |
| Sep 30, 2018 | 5,870.15% |
| Dec 31, 2017 | 462.29% |